ICON Gross Profit 2010-2023 | ICLR
ICON annual/quarterly gross profit history and growth rate from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- ICON gross profit for the quarter ending December 31, 2023 was $0.621B, a 6.74% increase year-over-year.
- ICON gross profit for the twelve months ending December 31, 2023 was $2.400B, a 8.39% increase year-over-year.
- ICON annual gross profit for 2023 was $2.4B, a 8.39% increase from 2022.
- ICON annual gross profit for 2022 was $2.214B, a 46.82% increase from 2021.
- ICON annual gross profit for 2021 was $1.508B, a 84.51% increase from 2020.
| ICON Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $2,400 |
| 2022 | $2,214 |
| 2021 | $1,508 |
| 2020 | $817 |
| 2019 | $832 |
| 2018 | $778 |
| 2017 | $731 |
| 2016 | $705 |
| 2015 | $666 |
| 2014 | $600 |
| 2013 | $491 |
| 2012 | $397 |
| 2011 | $334 |
| 2010 | $359 |
| 2009 | $380 |
| ICON Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2023-12-31 | $621 |
| 2023-09-30 | $606 |
| 2023-06-30 | $591 |
| 2023-03-31 | $583 |
| 2022-12-31 | $581 |
| 2022-09-30 | $567 |
| 2022-06-30 | $543 |
| 2022-03-31 | $523 |
| 2021-12-31 | $528 |
| 2021-09-30 | $508 |
| 2021-06-30 | $240 |
| 2021-03-31 | $232 |
| 2020-12-31 | $225 |
| 2020-09-30 | $208 |
| 2020-06-30 | $174 |
| 2020-03-31 | $210 |
| 2019-12-31 | $217 |
| 2019-09-30 | $211 |
| 2019-06-30 | $204 |
| 2019-03-31 | $199 |
| 2018-12-31 | $200 |
| 2018-09-30 | $196 |
| 2018-06-30 | $192 |
| 2018-03-31 | $190 |
| 2017-12-31 | $188 |
| 2017-09-30 | $181 |
| 2017-06-30 | $181 |
| 2017-03-31 | $181 |
| 2016-12-31 | $184 |
| 2016-09-30 | $177 |
| 2016-06-30 | $173 |
| 2016-03-31 | $172 |
| 2015-12-31 | $174 |
| 2015-09-30 | $168 |
| 2015-06-30 | $164 |
| 2015-03-31 | $160 |
| 2014-12-31 | $160 |
| 2014-09-30 | $158 |
| 2014-06-30 | $149 |
| 2014-03-31 | $133 |
| 2013-12-31 | $130 |
| 2013-09-30 | $126 |
| 2013-06-30 | $120 |
| 2013-03-31 | $217 |
| 2012-12-31 | $108 |
| 2012-09-30 | $102 |
| 2012-06-30 | $97 |
| 2012-03-31 | $181 |
| 2011-12-31 | $84 |
| 2011-09-30 | $82 |
| 2011-06-30 | $82 |
| 2011-03-31 | $161 |
| 2010-12-31 | $92 |
| 2010-09-30 | $86 |
| 2010-06-30 | $93 |
| 2010-03-31 | $178 |
| 2009-12-31 | $96 |
| 2009-09-30 | $93 |
| 2009-06-30 | $95 |
| 2009-03-31 | $96 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $24.074B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.212B | 15.32 |
| Cencora (COR) | United States | $47.337B | 18.89 |
| DiDi Global (DIDIY) | China | $22.638B | 0.00 |
| Avantor (AVTR) | United States | $16.482B | 22.71 |
| CochLear (CHEOY) | $13.356B | 0.00 | |
| Viatris (VTRS) | United States | $13.340B | 3.81 |
| Revvity (RVTY) | United States | $12.276B | 21.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.721B | 21.37 |
| Medpace Holdings (MEDP) | United States | $11.598B | 42.15 |
| Solventum (SOLV) | United States | $11.046B | 0.00 |
| Natera (NTRA) | United States | $10.540B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.851B | 51.19 |
| Bausch + Lomb (BLCO) | Canada | $5.032B | 19.35 |
| Doximity (DOCS) | United States | $4.630B | 34.47 |
| Organon (OGN) | United States | $4.566B | 4.42 |
| Sotera Health (SHC) | United States | $3.085B | 15.14 |
| Progyny (PGNY) | United States | $3.064B | 51.42 |
| Surgery Partners (SGRY) | United States | $2.965B | 27.55 |
| Life Times (LTH) | United States | $2.756B | 30.46 |
| GoodRx Holdings (GDRX) | United States | $2.658B | 134.60 |
| Premier (PINC) | United States | $2.491B | 9.12 |
| Teladoc Health (TDOC) | United States | $2.232B | 0.00 |
| Agilon Health (AGL) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.133B | 6.90 |
| BrightSpring Health Services (BTSG) | United States | $1.762B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.444B | 0.00 | |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.964B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
| Embecta (EMBC) | United States | $0.596B | 3.94 |
| Auna S.A (AUNA) | Luxembourg | $0.549B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.507B | 45.96 |
| MultiPlan (MPLN) | United States | $0.475B | 0.00 |
| Beauty Health (SKIN) | United States | $0.423B | 0.00 |
| CareDx (CDNA) | United States | $0.418B | 0.00 |
| LifeMD (LFMD) | United States | $0.412B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.356B | 57.00 |
| Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
| ModivCare (MODV) | United States | $0.286B | 3.79 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.249B | 0.00 |
| Sharecare (SHCR) | United States | $0.227B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.119B | 40.00 |
| Oncology Institute (TOI) | United States | $0.091B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.015B | 0.00 | |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |